Qualitative study on barriers and facilitators to genetic testing in Hispanic patients with prostate cancer.

BACKGROUND

Despite the importance of germline genetic evaluation in prostate cancer (PCa), fewer U.S. Hispanic patients receive it.

METHODS

We conducted semi-structured in-depth interviews with U.S. Hispanic patients with PCa in English or Spanish on facilitators and barriers to germline genetic testing.

RESULTS

Barriers and facilitators were multidimensional. Key facilitators include family benefit, actionability, trust in clinicians, bilingual educational materials and insurance coverage; whereas key barriers include confusion with other tests, fear of negative implications, low awareness and limited clinician-led counseling.

CONCLUSIONS

Bilingual informational materials, public messaging, and greater clinician education are needed to promote equity in PCa genetic evaluation.